Label: LINCOMYCIN- lincomycin injection
- NDC Code(s): 58005-636-04
- Packager: Sparhawk Laboratories, Inc.
- Category: PRESCRIPTION ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Animal Drug Application
Drug Label Information
Updated November 21, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
INDICATIONS & USAGE
300 mg/mL
STERILE LINCOMYCIN INJECTION
Caution:Federal law restricts this drug to use by or on the order of a licenced veterinarian.
SWINE ANTIBIOTIC
Indicated for the treatment of arthritis caused by susceptible ortanisims and for mycoplasma pneumonia.
Lincomycin Injectable contains lincomycin hydrochloride, an antibiotic produced bySteptomyces lincolnensis var. lincolnensis, which is chemically distinct from all other clinically avaialbel antibiotics and is isolated as a white crystalline solid
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Not for Use in Humans
Keep out of reach of childrenINDICATIONS FOR SWINE
Lincomycin injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci,Erysipelothrix and Mycoplasma spp.
- CONTRAINDICATIONS
- WARNING
- CAUTION
-
ADVERSE REACTIONS
The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect had rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.
-
CONTACT INFORMATION
To report suspected adverse events, for technical assistance or to obtain a copy of the Safety Data Sheet, contact Sparhawk Laboratories Inc at 1-800-255-6388 or 1-913-888-7500. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae
-
DOSAGE AND ADMINISTRATION
For arthritis or mycoplasma pneumonia-5mg per pound of body weight intramuscularly once daily for three to seven days as needed. When using lincomycin injection containing 25 mg/mL, 1 mL/5 lb. body weight will provide 5 mg/lb.
When using lincomycin injection containing 100 mg/mL, 1mL/20lb body weight will provide 5mg/lb. When using lincomycin injection containing 300 mg/mL, 1 mL/60 lb. body weight will provide 5 mg/lb.
For optimal results, initiate treatment as soon as possible. As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times. -
HOW SUPPLIED
Lincomycin Injectable is available in three concentrations: 300 mg/mL, 100 mg/mL and 25 mg/mL
300 mg/mL: For use in swine weighing 300 pounds or more. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 300 mg, also Benzyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.
100 mg/mL: Each mL contains lincomycin hydrochloride equivalent to lincomycin, 100 mg; also Benzyl Alcohol, 9,45 mg added as preservative. Supplied in 100 mL vials.
25 mg/mL: Special baby pig concentration. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 25 mg; also Benyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.
- STORAGE AND HANDLING
- Lincomycin 300
-
INGREDIENTS AND APPEARANCE
LINCOMYCIN
lincomycin injectionProduct Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:58005-636 Route of Administration INTRAMUSCULAR Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LINCOMYCIN HYDROCHLORIDE (UNII: M6T05Z2B68) (LINCOMYCIN - UNII:BOD072YW0F) LINCOMYCIN 300 mg in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58005-636-04 100 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANADA ANADA200315 01/21/2004 Labeler - Sparhawk Laboratories, Inc. (147979082)